Cargando…
Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer
Lung cancer accounts for the majority of cancer-related deaths worldwide of which non-small-cell lung carcinoma alone takes a toll of around 85%. Platinum-based therapy is the stronghold for lung cancer at present. The discovery of various molecular alterations that underlie lung cancer has contribu...
Autores principales: | Rose-James, Alphy, TT, Sreelekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475585/ https://www.ncbi.nlm.nih.gov/pubmed/26316937 http://dx.doi.org/10.1155/2012/729532 |
Ejemplares similares
-
Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers()()
por: Catacchio, Ivana, et al.
Publicado: (2018) -
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
por: Pavicevic, Sandra, et al.
Publicado: (2022) -
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
por: Brueckl, Wolfgang M., et al.
Publicado: (2020) -
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer
por: Hibner, Grzegorz, et al.
Publicado: (2018) -
Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer †
por: Aziz, Faisal, et al.
Publicado: (2022)